{"schema_version":"secwatch.filing_event.v1","accession":"0001372514-23-000053","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.663889+00:00","generated_at":"2026-06-17T09:05:15.823080+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kiora Pharmaceuticals dismisses EisnerAmper, appoints Haskell & White as auditor","bullets":["Dismissed EisnerAmper effective March 24, 2023 after competitive bid process.","No disagreements with EisnerAmper; material weakness in internal controls noted.","Prior audit report included going concern explanatory paragraph.","Appointed Haskell & White LLP as independent auditor for fiscal year 2023.","No prior consultations with Haskell & White on accounting matters."],"urls":{"canonical":"https://secwatch.observer/filing/0001372514-23-000053","json":"https://secwatch.observer/filing/0001372514-23-000053.json","markdown":"https://secwatch.observer/filing/0001372514-23-000053.md","text":"https://secwatch.observer/filing/0001372514-23-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000053/0001372514-23-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000053/kprx-20230324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:05:15.823080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c32381953fcfdbdebbba9a45fa67eddbe75608a","claim":"KIORA PHARMACEUTICALS INC engaged Haskell & White LLP as its auditor.","evidence_excerpt":"the Audit Committee has appointed Haskell & White LLP as the Company’s independent registered public accounting firm, effective March 24, 2023","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000053/0001372514-23-000053-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Haskell & White LLP"}],"fact_type":"auditor_change"},{"claim_id":"c9f1b73338b76cacd0efb7f4f7d4a55da3ce72e5","claim":"KIORA PHARMACEUTICALS INC dismissed EisnerAmper LLP as its auditor.","evidence_excerpt":"the Audit Committee dismissed EisnerAmper as the Company’s independent registered public accounting firm as of the Effective Date","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000053/0001372514-23-000053-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"EisnerAmper LLP"},{"label":"Successor","value":"Haskell & White LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}